Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrykowski, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrykowski, M. A.

Psychosomatic Medicine, Vol 52, Issue 4 458-475, Copyright © 1990 by American Psychosomatic Society

ORIGINAL ARTICLES

The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis

MA Andrykowski
Department of Behavioral Science, University of Kentucky College of Medicine, Lexington 40536-0086.

The role of state anxiety in the development of anticipatory nausea and vomiting (ANV) in cancer chemotherapy has been the focus of considerable empirical investigation and theoretical speculation. However, while some relationship between state anxiety and ANV is presumed to exist, determination of its precise nature has proven elusive. Specific hypotheses linking state anxiety to ANV are described and evaluated in light of the empirical evidence. These hypotheses include (a) ANV is a symptomatic concomitant of state anxiety; (b) state anxiety directly facilitates the classical conditioning of ANV; (c) state anxiety exacerbates the magnitude of post-treatment nausea and vomiting experienced, thus increasing the risk of ANV; (d) ANV causes infusion-related state anxiety; and (e) the observed relationship between ANV and state anxiety is a result of methodological artifact. It is concluded that state anxiety can play a causal role in the development of ANV in some patients. In particular, the hypothesis that state anxiety exacerbates post-treatment nausea and vomiting and thus increases the risk for ANV appears best supported by the data. Finally, the clinical implications of the relationship between ANV and state anxiety for the treatment and prevention of ANV are discussed.


This article has been cited by other articles:


Home page
 JAMAHome page
G. J. Wood, J. W. Shega, B. Lynch, and J. H. Von Roenn
Management of Intractable Nausea and Vomiting in Patients at the End of Life: "I Was Feeling Nauseous All of the Time . . . Nothing Was Working"
JAMA, September 12, 2007; 298(10): 1196 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
V. A. Rhodes and R. W. McDaniel
Nausea, Vomiting, and Retching: Complex Problems in Palliative Care
CA Cancer J Clin, July 1, 2001; 51(4): 232 - 248.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. J. Gralla, D. Osoba, M. G. Kris, P. Kirkbride, P. J. Hesketh, L. W. Chinnery, R. Clark-Snow, D. P. Gill, S. Groshen, S. Grunberg, et al.
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
J. Clin. Oncol., September 1, 1999; 17(9): 2971 - 2971.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Psychosomatic Society